z-logo
open-access-imgOpen Access
Utility of OCT3/4, TSPY andβ-Catenin as Biological Markers for Gonadoblastoma Formation and Malignant Germ Cell Tumor Development in Dysgenetic Gonads
Author(s) -
Ícela Palma-Lara,
Nayely Garibay-Nieto,
Rocio Pena-Yolanda,
Alejandra ContrerasRamos,
Atlantida Raya,
Carolina Domínguez,
Mirna Romero,
Gerardo Aristi,
Gloria Queipo
Publication year - 2013
Publication title -
disease markers
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.912
H-Index - 66
eISSN - 1875-8630
pISSN - 0278-0240
DOI - 10.1155/2013/951751
Subject(s) - gonadoblastoma , dysgerminoma , seminoma , gonadal dysgenesis , testicular germ cell tumor , gonocyte , wnt signaling pathway , biology , germ cell , cancer research , pathology , medicine , ovary , endocrinology , genetics , chemotherapy , gene , karyotype , chromosome
BACKGROUND: Gonadoblastoma (GB) is regarded as an in situ form of germ cell tumor in dysgenetic gonads, and 30% of patients with GB develop a dysgerminoma/seminoma tumor. OBJECTIVE: Determine whether OCT3/4 and β -catenin are expressed in dysgenetic gonads before GB development and whether TSPY participates in the OCT3/4- β -catenin pathways in the malignant invasive behavior. METHODS: dysgenetic gonads of Disorders of sex differentiation (DSD) patients with mixed gonadal dysgenesis were analyzed by immunohistochemistry and immunofluorescence for comparison with GB and dysgerminoma/seminoma. RESULTS: Our results suggest that the development of GB is secondary to the interaction of OCT3/4 and TSPY, that β -catenin does not participate in this process. CONCLUSIONS: The use of this biological markers detects the potential high risk gonads.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom